Impaired fasting glycaemia

From Wikipedia, the free encyclopedia

Diabetes mellitus
Types of Diabetes
Diabetes mellitus type 1 Diabetes mellitus type 2 Gestational diabetes Pre-diabetes: Impaired fasting glycaemia Impaired glucose tolerance
Disease Management
Diabetes management: •Diabetic diet •Anti-diabetic drugs •Conventional insulinotherapy •Intensive insulinotherapy
Other Concerns
Cardiovascular disease Diabetic comas: •Diabetic hypoglycemia •Diabetic ketoacidosis •Nonketotic hyperosmolar Diabetic myonecrosis Diabetic nephropathy Diabetic neuropathy Diabetic retinopathy Diabetes and pregnancy
Blood tests
Blood sugar Fructosamine Glucose tolerance test Glycosylated hemoglobin

Impaired fasting glycaemia (IFG) is a pre-diabetic state of dysglycemia, associated with insulin resistance and increased risk of cardiovascular pathology, although of lesser risk than Impaired glucose tolerance (IGT). IFG often progresses to type 2 diabetes mellitus, a recent study citing the average time for progression as less than three years.^[1] IFG is also a risk factor for mortality.^[2]

It is characterised by an intermediately raised fasting glucose level, but less than would qualify for type 2 diabetes mellitus. On challenging with an oral glucose tolerance test, normal blood glucose levels are maintained after 2 hours, unlike IGT.

[edit] Criteria

fasting glucose level > 5.6 mmol/l (100 mg/dl) and < 6.9 mmol/l (125mg/dl).^[3]^[4]

The criteria will continue to change as many endocrinologists believe an impaired fasting glycose may eventually include fasting glucose between a high 95-100 mg/dl.^{[citation needed]}